CHAT and Alzheimer disease: While glycyrrhizic acid treatment did not affect ChAT+IR neuron populations in CONs, it reversed the AIE-induced acceleration of AD-associated ChAT+ basal forebrain cholinergic neuron loss (Tukey’s HSD: p = 0.0003; see Figure 8).